RVMD Today - Aug 11: Collaboration with BeOne Medicines
Unable to add items
Sorry, we're unable to add the item because your cart is already full.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Failed to remove from Wish List.
Please try again later
Adding to library failed
Please try again
Unable to follow podcast
Unable to unfollow podcast
RVMD Today - Aug 11: Collaboration with BeOne Medicines
-
Narrated by:
-
By:
What happened? Well, the stock had a bit of a rough day. It opened strong but lost some steam as the day went on. It got smoked a bit, but honestly, it wasn’t a huge surprise given the market vibes.
Now, let’s talk about why this happened. There’s some buzz around a new collaboration with BeOne Medicines for oncology therapies. That sounds great on paper—like a solid partnership for tackling cancer. But sometimes, these deals can bring mixed feelings. Investors might be thinking about how this affects RVMD’s valuation. Some folks are excited, but others are a bit cautious, especially with Bank of America cutting their holdings in RVMD. Yeah, that one stung for sure. It’s like when your friend tells you they’re not feeling your favorite band anymore, and you’re left wondering if you should still rock out to their tunes.
Also, TD Cowen reiterated a “Buy” rating on the stock, which is a positive sign. But with the mixed signals from the market, it’s like a rollercoaster of emotions for investors.
One thing worth keeping in mind is that RVMD recently hit a new 12-month high. That’s a big deal! It shows that there’s been some serious interest in the stock lately.
So, to wrap it up, RVMD had a bit of a tough day, but there are some exciting developments happening. Just remember, this is all for fun and info. I’m not here to tell you what to do with your money. Just keep an eye on the news and do what feels right for you. Catch you later!
adbl_web_anon_alc_button_suppression_t1
No reviews yet
